11-64648295-G-A

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_015080.4(NRXN2):​c.3327C>T​(p.Gly1109=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.142 in 1,614,120 control chromosomes in the GnomAD database, including 17,627 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1347 hom., cov: 32)
Exomes 𝑓: 0.14 ( 16280 hom. )

Consequence

NRXN2
NM_015080.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.0180
Variant links:
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
NRXN2-AS1 (HGNC:40416): (NRXN2 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 11-64648295-G-A is Benign according to our data. Variant chr11-64648295-G-A is described in ClinVar as [Benign]. Clinvar id is 129835.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.018 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.176 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
NRXN2NM_015080.4 linkuse as main transcriptc.3327C>T p.Gly1109= synonymous_variant 17/23 ENST00000265459.11 NP_055895.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
NRXN2ENST00000265459.11 linkuse as main transcriptc.3327C>T p.Gly1109= synonymous_variant 17/235 NM_015080.4 ENSP00000265459 P4Q9P2S2-1
NRXN2-AS1ENST00000433606.1 linkuse as main transcriptn.180+1717G>A intron_variant, non_coding_transcript_variant 3

Frequencies

GnomAD3 genomes
AF:
0.115
AC:
17515
AN:
152152
Hom.:
1348
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0299
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.0888
Gnomad ASJ
AF:
0.0496
Gnomad EAS
AF:
0.185
Gnomad SAS
AF:
0.134
Gnomad FIN
AF:
0.242
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.151
Gnomad OTH
AF:
0.110
GnomAD3 exomes
AF:
0.136
AC:
34185
AN:
251360
Hom.:
2627
AF XY:
0.139
AC XY:
18832
AN XY:
135864
show subpopulations
Gnomad AFR exome
AF:
0.0279
Gnomad AMR exome
AF:
0.0887
Gnomad ASJ exome
AF:
0.0528
Gnomad EAS exome
AF:
0.187
Gnomad SAS exome
AF:
0.128
Gnomad FIN exome
AF:
0.226
Gnomad NFE exome
AF:
0.150
Gnomad OTH exome
AF:
0.144
GnomAD4 exome
AF:
0.145
AC:
211729
AN:
1461850
Hom.:
16280
Cov.:
33
AF XY:
0.144
AC XY:
104907
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.0229
Gnomad4 AMR exome
AF:
0.0865
Gnomad4 ASJ exome
AF:
0.0530
Gnomad4 EAS exome
AF:
0.209
Gnomad4 SAS exome
AF:
0.124
Gnomad4 FIN exome
AF:
0.219
Gnomad4 NFE exome
AF:
0.150
Gnomad4 OTH exome
AF:
0.137
GnomAD4 genome
AF:
0.115
AC:
17508
AN:
152270
Hom.:
1347
Cov.:
32
AF XY:
0.119
AC XY:
8850
AN XY:
74436
show subpopulations
Gnomad4 AFR
AF:
0.0299
Gnomad4 AMR
AF:
0.0886
Gnomad4 ASJ
AF:
0.0496
Gnomad4 EAS
AF:
0.185
Gnomad4 SAS
AF:
0.133
Gnomad4 FIN
AF:
0.242
Gnomad4 NFE
AF:
0.151
Gnomad4 OTH
AF:
0.108
Alfa
AF:
0.136
Hom.:
2963
Bravo
AF:
0.102
Asia WGS
AF:
0.175
AC:
607
AN:
3478
EpiCase
AF:
0.133
EpiControl
AF:
0.137

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 04, 2020- -
not specified Benign:1
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
NRXN2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesNov 04, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
15
DANN
Benign
0.80

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3825074; hg19: chr11-64415767; COSMIC: COSV55461527; COSMIC: COSV55461527; API